Cas:173037-37-1 methyl 4-benzyl-2-phenyl-1,3-oxazole-5-carboxylate manufacturer & supplier

Chemical Name:methyl 4-benzyl-2-phenyl-1,3-oxazole-5-carboxylate

CAS.NO:173037-37-1

Synonyms:methyl 4-benzyl-2-phenyloxazole-5-carboxylate

Molecular Formula:C₁₈H₁₅NO₃

Molecular Weight:293.31700

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.33000

Exact Mass:293.10500

LogP:3.71900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl 4-benzyl-2-phenyloxazole-5-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 4-benzyl-2-phenyloxazole-5-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 4-benzyl-2-phenyloxazole-5-carboxylate Use and application,methyl 4-benzyl-2-phenyloxazole-5-carboxylate technical grade,usp/ep/jp grade.

Related News: Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management. methyl 4-benzyl-2-phenyl-1,3-oxazole-5-carboxylate manufacturer The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. methyl 4-benzyl-2-phenyl-1,3-oxazole-5-carboxylate supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry. methyl 4-benzyl-2-phenyl-1,3-oxazole-5-carboxylate vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. methyl 4-benzyl-2-phenyl-1,3-oxazole-5-carboxylate factory Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.